Xie Hailiang, Lu Jiying, Zheng Guofu, Liu Xiaochun, Chen Weiqing
Department of General Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi, People's Republic of China.
School of medical Jiangsu university, Zhenjiang, Jiangsu, People's Republic of China.
Sci Prog. 2025 Jan-Mar;108(1):368504251320766. doi: 10.1177/00368504251320766.
Data regarding the long-term outcomes of patients with thromboangiitis obliterans (TAO) after drug therapy (DT) alone and endovascular procedure (EP)+ drug therapy (DT) are limited. In this study, we compared the long-term outcomes and prognostic factors of major amputation in TAO patients treated with DT alone and those treated with EP+ DT.
Consecutive patients with TAO treated at Ganzhou People's Hospital between 2012 and 2022 were included in this real-world study. All patients were administered DT. Some patients were treated with EP in addition to DT. The patients were classified into two groups: the DT group and the EP+ DT group. Long-term follow-up was sustained for all patients after treatment, and limb events were documented throughout the follow-up period. Cox regression analyses were used to analyze the factors associated with major amputation of the TAO.
A total of 150 TAO patients with 175 lower limb lesions were included in the study and the number of patients in DT group and EP+ DT group was 81 and 69, respectively. The technical success rate in the EP group was 82.6%. The major amputation was performed in 19 and 21 patients in the respective groups, accounting for 26.7% of the total patients. The Kaplan-Meier curves for major amputation did not significantly differ between the two groups. Cox regression analysis revealed that disease duration (hazard ratio (HR), 0.865; 95% confidence interval (CI) [0.783-0.979], = 0.005), wound grade (HR, 2.240; 95% CI 1.565-3.207], < 0.001) and current smoking (HR, 3.075; 95% CI 1.317-7.812], = 0.009) were independent factors for major amputation in patients with TAO.
In terms of long-term outcomes, major amputation in TAO patients did not seem to be related to the treatment methods despite a higher immediate patency rate observed after endovascular procedures. Additionally, we identified independent factors for major amputation.
关于血栓闭塞性脉管炎(TAO)患者单纯药物治疗(DT)以及血管内介入治疗(EP)联合药物治疗后的长期预后数据有限。在本研究中,我们比较了TAO患者单纯接受DT治疗与接受EP联合DT治疗后的长期预后及大截肢的预后因素。
本项真实世界研究纳入了2012年至2022年期间在赣州市人民医院接受治疗的连续性TAO患者。所有患者均接受DT治疗。部分患者在DT基础上还接受了EP治疗。患者被分为两组:DT组和EP + DT组。治疗后对所有患者进行长期随访,并在整个随访期间记录肢体事件。采用Cox回归分析来分析与TAO患者大截肢相关的因素。
本研究共纳入150例患有175处下肢病变的TAO患者,DT组和EP + DT组的患者数量分别为81例和69例。EP组的技术成功率为82.6%。两组分别有19例和21例患者接受了大截肢手术,占总患者数的26.7%。两组大截肢的Kaplan - Meier曲线无显著差异。Cox回归分析显示,病程(风险比(HR),0.865;95%置信区间(CI)[0.783 - 0.979],P = 0.005)、伤口分级(HR,2.240;95% CI 1.565 - 3.207],P < 0.001)和当前吸烟情况(HR,3.075;95% CI 1.317 - 7.812],P = 0.009)是TAO患者大截肢的独立因素。
就长期预后而言,尽管血管内介入治疗后即刻通畅率较高,但TAO患者的大截肢似乎与治疗方法无关。此外,我们确定了大截肢的独立因素。